tiprankstipranks
Advertisement
Advertisement

GRTX Stock Latest News

Galera Therapeutics Eliminates Series B Preferred, Simplifies Equity
Company AnnouncementsGalera Therapeutics Eliminates Series B Preferred, Simplifies Equity
14d ago
8K
GRTX
Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights
PremiumCompany Announcements
Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights
18d ago
8K
GRTX
Galera Shareholders Approve Governance Changes and Share Increase
PremiumCompany Announcements
Galera Shareholders Approve Governance Changes and Share Increase
21d ago
8K
GRTX
Galera Announces Obsidian Merger and $350M Financing
PremiumCompany Announcements
Galera Announces Obsidian Merger and $350M Financing
2M ago
8K
GRTX
Galera Therapeutics, Obsidian Therapeutics enter merger agreement
PremiumThe Fly
Galera Therapeutics, Obsidian Therapeutics enter merger agreement
2M ago
GRTX
Galera Therapeutics Announces Share Conversions and Warrant Exercise
PremiumCompany AnnouncementsGalera Therapeutics Announces Share Conversions and Warrant Exercise
2M ago
8K
GRTX
Neogen appoints Stacey as Chief Legal & Compliance Officer
Premium
The Fly
Neogen appoints Stacey as Chief Legal & Compliance Officer
2M ago
GRTX
NEOG
Galera Sets Deadlines for 2026 Combined Annual Meeting
Premium
Company Announcements
Galera Sets Deadlines for 2026 Combined Annual Meeting
2M ago
8K
GRTX
Galera Therapeutics Updates Preferred Stock Conversion Provisions
PremiumCompany Announcements
Galera Therapeutics Updates Preferred Stock Conversion Provisions
3M ago
8K
GRTX
Galera Therapeutics Grants Retention Bonus to Key Officer
PremiumCompany Announcements
Galera Therapeutics Grants Retention Bonus to Key Officer
4M ago
8K
GRTX
Galera Therapeutics Sells Assets to Biossil Inc.
PremiumCompany Announcements
Galera Therapeutics Sells Assets to Biossil Inc.
7M ago
8K
GRTX
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M
PremiumThe Fly
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M
7M ago
GRTX
Galera Therapeutics Sells Assets to Biossil Inc.
PremiumCompany AnnouncementsGalera Therapeutics Sells Assets to Biossil Inc.
7M ago
8K
GRTX
Galera Therapeutics Amends Royalty Agreement with Clarus
Premium
Company Announcements
Galera Therapeutics Amends Royalty Agreement with Clarus
9M ago
8K
GRTX
Galera Therapeutics Expands with Nova Pharmaceuticals Acquisition
Premium
Company Announcements
Galera Therapeutics Expands with Nova Pharmaceuticals Acquisition
1y ago
8K
GRTX
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
PremiumThe Fly
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
1y ago
GRTX
Twelve option delistings on December 23rd
PremiumThe Fly
Twelve option delistings on December 23rd
1y ago
ATRA
BURU
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
PremiumThe Fly
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
2y ago
GRTX
URGN
Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting
PremiumCompany Announcements
Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting
2y ago
8K
GRTX
Galera Therapeutics reports Q2 EPS (7c) vs. (48c) last year
PremiumThe FlyGalera Therapeutics reports Q2 EPS (7c) vs. (48c) last year
2y ago
GRTX
Galera Therapeutics to reduce workforce to three employees
Premium
The Fly
Galera Therapeutics to reduce workforce to three employees
2y ago
GRTX
Galera Therapeutics announces board approval of liquidation, dissolution
Premium
The Fly
Galera Therapeutics announces board approval of liquidation, dissolution
2y ago
GRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >